Hwail Pharmaceutical Co.,Ltd. (KOSDAQ:061250)

South Korea flag South Korea · Delayed Price · Currency is KRW
9,430.00
-210.00 (-2.18%)
At close: Apr 6, 2026
Market Cap79.38B -11.6%
Revenue (ttm)107.87B -4.8%
Net Income1.92B -80.8%
EPS474.50 -80.9%
Shares Out8.42M
PE Ratio19.87
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume25,373
Average Volume36,780
Open9,640.00
Previous Close9,640.00
Day's Range9,430.00 - 9,770.00
52-Week Range9,020.00 - 14,700.00
Beta0.33
RSI37.90
Earnings Daten/a

About Hwail Pharmaceutical

Hwail Pharmaceutical Co.,Ltd. develops pharmaceutical raw materials in South Korea. It provides raw drug products, finished drug products, and functional health food raw material business. The company was founded in 1974 and is headquartered in Seongnam-si, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 1974
Employees 130
Stock Exchange KOSDAQ
Ticker Symbol 061250
Full Company Profile